Literature DB >> 25205017

Systemic biochemical markers of joint metabolism and inflammation in relation to radiographic parameters and pain of the knee: data from CHECK, a cohort of early-osteoarthritis subjects.

W E Van Spil1, S C Nair2, M B Kinds3, P J Emans4, W K H A Hilberdink5, P M J Welsing6, F P J G Lafeber7.   

Abstract

OBJECTIVE: To investigate associations of biochemical markers of joint metabolism and inflammation with minimum joint space width (JSW) and osteophyte area (OP area) of knees showing no or doubtful radiographic osteoarthritis (OA) and to investigate whether these differed between painful and non-painful knees.
DESIGN: Serum (s-) and urinary (u-) levels of the cartilage markers uCTX-II, sCOMP, sPIIANP, and sCS846, bone markers uCTX-I, uNTX-I, sPINP, and sOC, synovial markers sPIIINP and sHA, and inflammation markers hsCRP and erythrocyte sedimentation rate (ESR) were assessed in subjects from CHECK (Cohort Hip and Cohort Knee) demonstrating Kellgren and Lawrence grade ≤1 OA on knee radiographs. Minimum JSW and OP area of these knees were quantified in detail using Knee Images Digital Analysis (KIDA).
RESULTS: uCTX-II levels showed negative associations with minimum JSW and positive associations with OP area. sCOMP and sHA levels showed positive associations with OP area, but not with minimum JSW. uCTX-I and uNTX-I levels showed negative associations with minimum JSW and OP area. Associations of biochemical marker levels with minimum JSW were similar between painful and non-painful knees, associations of uCTX-II, sCOMP, and sHA with OP area were only observed in painful knees.
CONCLUSIONS: In these subjects with no or doubtful radiographic knee OA, uCTX-II might not only reflect articular cartilage degradation but also endochondral ossification in osteophytes. Furthermore, sCOMP and sHA relate to osteophytes, maybe because synovitis drives osteophyte development. High bone turnover may aggravate articular cartilage loss. Metabolic activity in osteophytes and synovial tissue, but not in articular cartilage may be related to knee pain.
Copyright © 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biochemical markers; Inflammation; Joint space width; Osteoarthritis; Osteophytes

Mesh:

Substances:

Year:  2014        PMID: 25205017     DOI: 10.1016/j.joca.2014.09.003

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  11 in total

Review 1.  Sport and early osteoarthritis: the role of sport in aetiology, progression and treatment of knee osteoarthritis.

Authors:  F Vannini; T Spalding; L Andriolo; M Berruto; M Denti; J Espregueira-Mendes; J Menetrey; G M Peretti; R Seil; G Filardo
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-04-04       Impact factor: 4.342

2.  Association Between Biochemical Markers of Bone Turnover and Bone Changes on Imaging: Data From the Osteoarthritis Initiative.

Authors:  Leticia A Deveza; Virginia B Kraus; Jamie E Collins; Ali Guermazi; Frank W Roemer; Michael Bowes; Michael C Nevitt; Christoph Ladel; David J Hunter
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-07-10       Impact factor: 4.794

3.  Plasma levels of interleukin-1 receptor antagonist (IL1Ra) predict radiographic progression of symptomatic knee osteoarthritis.

Authors:  M Attur; A Statnikov; J Samuels; Z Li; A V Alekseyenko; J D Greenberg; S Krasnokutsky; L Rybak; Q A Lu; J Todd; H Zhou; J M Jordan; V B Kraus; C F Aliferis; S B Abramson
Journal:  Osteoarthritis Cartilage       Date:  2015-11       Impact factor: 6.576

Review 4.  Phenotypes of osteoarthritis: current state and future implications.

Authors:  Leticia A Deveza; Amanda E Nelson; Richard F Loeser
Journal:  Clin Exp Rheumatol       Date:  2019-10-15       Impact factor: 4.473

5.  Can we identify patients with high risk of osteoarthritis progression who will respond to treatment? A focus on epidemiology and phenotype of osteoarthritis.

Authors:  Olivier Bruyère; Cyrus Cooper; Nigel Arden; Jaime Branco; Maria Luisa Brandi; Gabriel Herrero-Beaumont; Francis Berenbaum; Elaine Dennison; Jean-Pierre Devogelaer; Marc Hochberg; John Kanis; Andrea Laslop; Tim McAlindon; Susanne Reiter; Pascal Richette; René Rizzoli; Jean-Yves Reginster
Journal:  Drugs Aging       Date:  2015-03       Impact factor: 3.923

Review 6.  Mechanism and therapeutic effectiveness of nerve growth factor in osteoarthritis pain.

Authors:  Xiushuai Shang; Zhaofei Wang; Hairong Tao
Journal:  Ther Clin Risk Manag       Date:  2017-08-01       Impact factor: 2.423

7.  Associations between biomarkers of bone and cartilage turnover, gender, pain categories and radiographic severity in knee osteoarthritis.

Authors:  Asger Reinstrup Bihlet; Inger Byrjalsen; Anne-Christine Bay-Jensen; Jeppe Ragnar Andersen; Claus Christiansen; Bente Juel Riis; Morten A Karsdal
Journal:  Arthritis Res Ther       Date:  2019-09-03       Impact factor: 5.156

8.  Biomarkers in Painful Symptomatic Knee OA Demonstrate That MRI Assessed Joint Damage and Type II Collagen Degradation Products Are Linked to Disease Progression.

Authors:  Nidhi Sofat; Vivian Ejindu; Christine Heron; Abiola Harrison; Soraya Koushesh; Lena Assi; Anasuya Kuttapitiya; Guy S Whitley; Franklyn A Howe
Journal:  Front Neurosci       Date:  2019-10-15       Impact factor: 4.677

9.  Synovial fluid adipokines are associated with clinical severity in knee osteoarthritis: a cross-sectional study in female patients with joint effusion.

Authors:  Joan Calvet; Cristóbal Orellana; Jordi Gratacós; Antoni Berenguer-Llergo; Assumpta Caixàs; Juan José Chillarón; Juan Pedro-Botet; María García-Manrique; Noemí Navarro; Marta Larrosa
Journal:  Arthritis Res Ther       Date:  2016-09-15       Impact factor: 5.156

10.  Cartilage turnover and intra-articular corticosteroid injections in knee osteoarthritis.

Authors:  Rainer Klocke; Kirsty Levasseur; George D Kitas; Jacqueline P Smith; George Hirsch
Journal:  Rheumatol Int       Date:  2018-02-02       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.